ABSTRACT
BACKGROUND
Rapid antigen detection tests (RADT) are commonly used to guide appropriate antibiotic treatment of group A beta-hemolytic streptococcal (GABHS) pharyngitis. In adults, there is controversy about the need for routine backup testing of negative RADT.
OBJECTIVE
Estimate the costs and benefits in adults of routine backup testing by DNA Gen-probe of negative RADT (Acceava).
DESIGN
Observational follow-up study.
PARTICIPANTS
All patients aged 18 years and older visiting a Cleveland Clinic generalist physician in 2009 and 2010 with a visit diagnosis of acute pharyngitis (ICD codes 462, 034.0).
MAIN MEASURES
The patients were identified using the Cleveland Clinic Epic Clarity database. We determined the proportion of false negative RADT, antibiotic prescription patterns and rate of serious suppurative complications within 30 days of the office visit.
KEY RESULTS
Of 25,130 patients with acute pharyngitis, 19 % had no testing and 81 % were tested. Of the 15,555 patients that had a negative RADT and follow-up DNA probe, 6 % had a positive DNA probe. Of the 953 patients who had a negative RADT and a positive DNA strep probe, 48 % received an antibiotic prescription at the time of the visit and 51 % received an antibiotic prescription after an average of 2.3 days. Only one patient with a negative RADT and no follow-up DNA probe developed a peritonsillar abscess. Overall, of the 15,555 DNA probes performed, management was altered in only 3 % of the patients at a total cost of $1,757,715. Fifty-six percent received an antibiotic while only 19.5 % had a confirmed strep throat diagnosis.
CONCLUSIONS
The false negative rate of Acceava RADT for the diagnosis of GABHS pharyngitis was 6 %. We question the benefit of routine DNA probe backup testing in adults because of its substantial cost, an average delay in antibiotic prescribing of over 2 days, and because suppurative complications are very uncommon. We found a high rate of inappropriate antibiotic prescribing.
Similar content being viewed by others
REFERENCES
Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data. 2002;328:1–32.
Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. Natl Health Stat Report. 2008;8:1–29.
Bisno AL. Acute pharyngitis: etiology and diagnosis. Pediatrics. 1996;97:949–54.
Snow V, Mottur-Pilson C, Cooper RJ, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults. Ann Intern Med. 2001;134:506.
Linder JA. Evaluation and management of adult pharyngitis. Compr Ther. 2008;34(3–4):196–203.
Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis. 1997;25(3):574–83. Review.
Brook I, Dohar JE. Management of group A beta-hemolytic streptococcal pharyngotonsillitis in children. J Fam Pract. 2006;55(12):S1–11. quiz S12.
Randolph MF, Gerber MA, DeMeo KK, Wright L. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr. 1985;106:870–5.
Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis: placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA. 1985;253:1271–4.
Nelson JD. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis. Pediatr Infect Dis J. 1984;3:10–3.
Salkind AR, Wright JM. Economic burden of adult pharyngitis: the payer’s perspective. ISPOR. 2008;11:621–7.
Wannamaker LW. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child. 1972;124(3):352–8.
Kaplan EL, Top FH Jr, Dudding BA, Wannamaker LW. Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis. 1971;123(5):490–501.
Breese BB, Disney FA. The accuracy of diagnosis of beta-streptococcal infections on clinical grounds. J Pediatr. 1954;44:670–3.
Pokorski SJ, Vetter EA, Wollan PC, Cockerill FR 3rd. Comparison of Gen-Probe Group A streptococcus Direct Test with culture for diagnosing streptococcal pharyngitis. J Clin Microbiol. 1994;32:1440–3.
Heelan JS, Wilbur S, Depetris G, Letourneau C. Rapid antigen testing for group A Streptococcus by DNA probe. Diagn Microbiol Infect Dis. 1996;24:65–9.
Gerber MA. Comparison of throat cultures and rapid strep tests for diagnosis of streptococcal pharyngitis. Pediatr Infect Dis J. 1989;8:820–4.
Chapin KC, Blake P, Wilson CD. Performance characteristics and utilization of rapid antigen test, DNA probe, and culture for detection of group a streptococci in an acute care clinic. J Clin Microbiol. 2002;40(11):4207–10.
Rogo T, Schwartz RH, Ascher DP. Comparison of the Inverness Medical Acceava Strep A test with the Genzyme OSOM and Quidel QuickVue Strep A tests. Clin Pediatr. 2011;50:294–6.
Bourbeau PP, Heiter BJ. Use of swabs without transport media for the Gen-Probe Group A Strep Direct Test. J Clin Microbiol. 2004;42:3207–11.
Peter GS, Bisno AL. Group A streptococcal pharyngitis in adults: diagnosis and management. In: Pechera JC, Kaplan EL, eds. Streptococcal pharyngitis issues in infectious diseases. Basel. Karger. 2004;3:22.
Poses RM, Cebul RD, Collins M, Fager SS. The accuracy of experienced physicians’ probability estimates for patients with sore throats. Implications for decision making. JAMA. 1985;254:925.
Woods WA, Carter CT, Stack M, et al. Group A streptococcal pharyngitis in adults 30 to 65 years of age. South Med J. 1999;92:491.
Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989–1999. JAMA. 2001;286:1181.
Acknowledgements
Contributors
We are grateful to Serge Harb, MD, Kelly Nottingham, Virginia Molina and Sarah Schramm for their assistance in obtaining and organizing the clinical data used in this study.
Funders
This publication was made possible by the Case Western Reserve University/Cleveland Clinic CTSA Grant Number UL1 RR024989 from the National Center for Research Resources (NCRR) and the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR, NCATS or NIH.
Prior presentations
American College of Physicians, oral presentation, April 20th 2012.
Conflict of Interest
The authors declare that they do not have a conflict of interest
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakhoul, G.N., Hickner, J. Management of Adults with Acute Streptococcal Pharyngitis: Minimal Value for Backup Strep Testing and Overuse of Antibiotics. J GEN INTERN MED 28, 830–834 (2013). https://doi.org/10.1007/s11606-012-2245-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-012-2245-8